Ketamine IV for the prevention of depression in the elderly: new data

Published Date: 13 Mar 2023

Intravenous (IV) ketamine is effective in adults resistant to depression. The response was similar to that seen in younger patients, two new studies show.

Read Full News

Latest News

US Health Department Announces Over $700 Million to Combat Mental Health, Addiction, Homelessness

U.S. Health Secretary Robert F. Kennedy Jr. on Wednesday announced more than $700 million in ⁠new funding opportunities aimed at tackling mental illness, addiction and...

New US Medical Schools: Not Just Solving Shortages

New medical schools go beyond solving the shortage. They offer earlier clinical experience, up-to-date technology, and strong ties to the community.

Congo Ebola Outbreak May Be Worst Ever, Africa CDC Says

The head of Africa's Centres for Disease Control and Prevention warned on Tuesday that the Ebola outbreak in Congo could be the worst ever, saying that it could ⁠cost...

Body Language Cues Help Medical Students Bond With Patients

Whether you sit or stand, how you hold yourself and even your tone of voice can make a difference.

GLP-1s Tied to Lower Healthcare Use in Migraine Patients

A real-world analysis links GLP-1s to fewer acute-care visits and less treatment escalation in patients with chronic migraine, but randomized trials are needed to confirm any preventive benefit.

Bronchiolitis Care Varies Across Hospitals in Norway

The use of high-flow nasal cannula and continuous positive airway pressure in infants with bronchiolitis varies widely across hospitals in Norway.

Todays Updates

Timely ‘Nudges’ Help Spur Talks on Patient Care Goals

Simple well-timed prompts to clinicians and patients with advanced cancer can increase conversations around care goals, but clear documentation remains a challenge.

Todays Updates

Timely ‘Nudges’ Help Spur Talks on Patient Care Goals

Simple well-timed prompts to clinicians and patients with advanced cancer can increase conversations around care goals, but clear documentation remains a challenge.

Latest News

U.S. Health Secretary Robert F. Kennedy Jr. on Wednesday announced more than $700 million in ⁠new funding opportunities aimed at tackling mental illness, addiction and...

New medical schools go beyond solving the shortage. They offer earlier clinical experience, up-to-date technology, and strong ties to the community.

The head of Africa's Centres for Disease Control and Prevention warned on Tuesday that the Ebola outbreak in Congo could be the worst ever, saying that it could ⁠cost...

Whether you sit or stand, how you hold yourself and even your tone of voice can make a difference.

A real-world analysis links GLP-1s to fewer acute-care visits and less treatment escalation in patients with chronic migraine, but randomized trials are needed to confirm any preventive benefit.

The use of high-flow nasal cannula and continuous positive airway pressure in infants with bronchiolitis varies widely across hospitals in Norway.

News All Time

ED Overcrowding Linked to Near-Tenfold Rise in Deaths

The RCEM estimates 15,860 deaths were linked to long ED waits in 2025, nearly ten times the 2015 figure.

Europe Faces Growing Synthetic Opioids Risks as Drug Market Evolves, EU Agency Warns

Europe's illicit drug market is undergoing a rapid shift, with synthetic opioids emerging as a concern, although the ⁠region still experiences far fewer fatal overdoses than...

Bipolar: The Warning Signs GPs Can Miss

Bipolar takes an average of 9.5 years to diagnose from first presentation — here's what GPs can do to spot it sooner and intervene before crisis hits.

MRI Signs of Osteitis Pubis Are Common Without Groin Pain

A large population-based study finds that bone marrow oedema and symphyseal cleft signs are common incidental findings on pelvic MRI and do not correlate with self-reported pain.

US FDA to Review AI-based Tool to Predict Drug-related Liver Damage

The U.S. FDA's Center for Drug Evaluation and Research said on Wednesday it has accepted ⁠a letter of intent for an artificial intelligence-based drug development tool...

Bundibugyo Ebola Update: Are New Defenses on the Horizon?

Global health agencies are accelerating vaccine and therapeutic research because the Bundibugyo Ebola outbreak highlights the absence of approved countermeasures.

Pediatric Ketamine Sedation Not Tied to Serious AEs

Children receiving ketamine sedation in the ED rarely have serious side effects, but risks are slightly higher in those who are older, those with respiratory infections, or those receiving opioids.

NICE Recommends Mepolizumab for Uncontrolled COPD

Mepolizumab is the second biologic approved for eosinophilic COPD this year, joining dupilumab in offering an alternative to triple therapy alone.

Diabetic Ketoacidosis Diagnosed Beyond Lab Criteria

Not all patients in the emergency department diagnosed with diabetic ketoacidosis meet laboratory criteria; a study shows that physicians rely on clinical signs and symptoms.

Older Age Tied to Higher CT Positivity in Abdominal Pain

Older adults visiting the emergency department for abdominal pain have higher risks for CT positivity and hospital admission than younger adults, despite less specific symptoms.

Texas Firearm Injuries: ED Admits Up, Costs Nearly Double

Firearm injuries continue to strain Texas emergency departments, with increasing hospitalizations and nearly doubled charges underscoring the growing burden on healthcare systems and communities.

AI Decision Support in ED: Helpful Tool or Clinical Risk?

Research shows artificial intelligence has use in the emergency department, but how it’s implemented is key.

Australian Doctors Lukewarm on Latest Federal Budget

Australia's latest federal budget includes $25 billion extra for public hospitals but offers little new support for general practitioners and rural healthcare.

Spain’s Debate Over Obstetric Violence

Health leaders in Spain debate balancing maternal-fetal safety with respectful, informed care, spotlighting birth plans, staffing shortages and calls for public outcome reporting.

Nestle and Danone Face Fresh Scrutiny Over Infant Formula Recalls

Nestle and Danone are facing fresh scrutiny over the handling of infant formula contamination after reports published on Tuesday by French, Belgian and Swiss public ⁠media...

Adjunctive Tirofiban Gains Ground in Stroke

Three major studies suggest intravenous or intra-arterial tirofiban may improve reperfusion outcomes without excess safety risk in selected patients with acute ischemic stroke.

Recommended News For You

NEJM: Fluorescent guide can aid in the detection of tumors that are still present after breast cancer surgery.

Conditional EU Nod for Weekly Pill in Pediatric Glioma

A US health panel advises starting mammograms at age 40 rather than 50.

Researchers achieve a significant milestone in the management of anemia in chronic lymphocytic leukemia.

Diet and Prostate Cancer; TTFields OK'd for NSCLC; Cancer Studies Retracted

Legal, Recreational Marijuana Linked to Higher CUD Prevalence.

Cancer during young adulthood carries long-term mental toll, study finds

Recommended Articles For You

Understanding Melanoma: From Diagnosis to Healing and Excision in Denver 

Introducing the Corrected Calcium Calculator: A Revolutionary Tool in Medical Assessment  

A Comprehensive Guide to Living with Cutaneous T Cell Lymphoma: Tips & Strategies  

Unlocking the Power of Hematocrit: Exploring the Benefits of Blood Cell Counts 

Whats more on Hidoc Dr.

Medical Updates
KOL Videos
Surveys
Events

Daily news to keep you up to date

Gain valuable insights with our in-depth KOL Video discussions

Participate and win cash vouchers

Get updates on the latest events happening around the world
Featured News
Featured Articles
Featured Events
Featured KOL Videos

1.

Belantamab Mafodotin: The Comeback Drug in Multiple Myeloma

2.

For older patients with Hodgkin lymphoma, novel regimens produce high response rates.

3.

Prostate cancer explained: From antigen tests to treatment options

4.

The importance of breast cancer screening

5.

Dual Targeted CAR-T Yields 99% Response Rate in Pediatric ALL

1.

The Essential Roadmap for Nutritional Excellence in Head and Neck Cancer Care

2.

The Mystery of Carotid Body Tumors: The Facts You Need to Know

3.

Oncology Trials Roadmap: From Drug Discovery to Delivery and Patient Access

4.

Myeloproliferative Disorders: Causes, Symptoms and Treatment Options 

5.

Cutting-Edge Cancer Treatments: Innovations and Outcomes in Non-Hodgkin Lymphoma

1.

Asian Symposium on Advancement in Hematology and Oncology

2.

Asian Symposium on Advancement in Hematology and Oncology

3.

International Cancer Conference

4.

Asian Symposium on Advancement in Hematology and Oncology

5.

International Lung Cancer Congress®

1.

Navigating the Complexities of Ph Negative ALL - Part XV

2.

Breaking Down PALOMA-2: How CDK4/6 Inhibitors Redefined Treatment for HR+/HER2- Metastatic Breast Cancer

3.

Recent Data Analysis for First-Line Treatment of ALK+ NSCLC: A Continuation

4.

Key Takeaways from The CROWN Trial For ALK + NSCLC Patients with CNS Diseases

5.

The Landscape of First-Line Treatment for Urothelial Carcinoma- The Conclusion

Fastest Growing Medical Platform for Doctors

Address :
Hidoc Dr. Inc. | Delaware C Corp | 1309 Coffeen Ave. Suite 1200, Sheridan WY, 82801

Phone :
+1-415-463-3094

Email :
anishagadia@hidoc.co

Quick Links

Drug DatabaseDrug InteractionDiseases Database
KOL VideosKnowledge HubQuizzes
Medical UpdatesEventsAbout Us

© Copyright 2026 Hidoc Dr. Inc.

Terms & Conditions - LLP | Inc. | Privacy Policy - LLP | Inc. | Account Deactivation
Home
Profile
Login
bot